Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track SXTC with free AI briefings, catalyst countdowns, and dilution alerts.

SXTC · China SXT Pharmaceuticals, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$28.3M Cash on Hand
84.6mo Cash Runway
Follow SXTC by email Get an email when SXTC reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about SXTC, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

SXTC holds $28.3M in cash and short-term investments and burns about $1M/quarter from operations, an estimated runway of 84.6 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 40 · Elevated

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when SXTC files for a raise →

👥 Who Owns SXTC

Insiders 0% Other 5%+ holders 100% Institutions 0% Public and other holders 0%
HolderTypeShares% of sharesAs of
Orca Capital AG 5%+ holder (13G) 1,112,788 116.15% 2026-10-08
Feng Felix Zhou
Co-CEO and Director, Director
Insider 4 0.00% 2017-07-04

Share count 958,077 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the largest 13F holders. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full SXTC picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for SXTC and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.